Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation



Status:Withdrawn
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:18 - Any
Updated:7/8/2018
Start Date:December 2017
End Date:August 2024

Use our guide to learn which trials are right for you!

A Prospective Randomized Single Blinded Study of Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation

The purpose of this study is to investigate a promising strategy to improve maturation and
patency rates following creation of AV fistulas and assess whether an anastomosis performed
with Anastoclips (interrupted, nonpenetrating) would produce better maturation and/or patency
than one performed with conventional suturing techniques.

This will be a single blind (patient and dialysis center), prospective, randomized trial
conducted at a single center. The study intervention will be randomization between
conventional sutured anastomosis (Control group) and use of Anastoclips (Treatment group),
which provide an interrupted closure without intimal penetration.

Inclusion Criteria:

- Requiring brachiocephalic fistula judged to be best option for access after vein
mapping (Surgeons will be required to do 10 cases using Anastoclips prior to
enrolling)

- Able to provide informed consent in English or Spanish

- Age 18 years or greater

- With estimated life expectancy of 2 years or more

- Able to comply with study procedures including all scheduled follow-up visits

Exclusion Criteria:

- Unable to provide informed consent in English or Spanish

- Age < 18 years

- With pacemaker, IACD, or other permanent obstructive device on that side (a temporary
tunneled dialysis catheter is not an exclusion)

- Unable (or in surgeon's judgment a poor risk) to comply with study procedures and
follow-up visits

- With estimated life expectancy of less than 2 years

- Females must be either:

- Of non-childbearing potential, which is defined as post-menopausal (at least 12
months without menses prior to Treatment Day) or documented surgically sterile or
post hysterectomy (at least 1 month prior to Treatment Day)

- Or, of childbearing potential, in which case must have a negative urine pregnancy
test at Treatment Day
We found this trial at
3
sites
1 Tampa General Cir
Tampa, Florida 33606
(813) 844-7000
Principal Investigator: Karl Illig, MD
Phone: 813-844-4133
Tampa General Hospital In a diverse city known for its rich culture and beautiful beaches,...
?
mi
from
Tampa, FL
Click here to add this to my saved trials
2 Tampa General Circle
Tampa, Florida 33606
Principal Investigator: Karl Illig, MD
Phone: 813-844-4133
?
mi
from
Tampa, FL
Click here to add this to my saved trials
13330 USF Laurel Drive
Tampa, Florida 33612
Principal Investigator: Karl Illig, MD
Phone: 813-844-4133
?
mi
from
Tampa, FL
Click here to add this to my saved trials